Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stavudine Dose Reduction vs Switching to Tenofovir in HIV Lipoatrophy
NCT00312832Phase 4Completed
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Jan 2004
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of stavudine, tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by Hospital Clínic de Barcelona. Started Jan 2004; status: completed.
02
Drugs
stavudinetenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00312832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312832.